询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
4-Chloro-2-trifluoromethylbenzylamine | CAS:771583-81-4
4-Chloro-2-trifluoromethylbenzylamine
  • 名称:4-氯-2-三氟甲基苄胺 | 4-Chloro-2-trifluoromethylbenzylamine
  • CAS号:771583-81-4
  • 别名:(4-Chloro-2-(trifluoromethyl)phenyl)methanamine; 1-[4-Chloro-2-(trifluoromethyl)phenyl]methanamine
  • 分子式:C8H7ClF3N
  • 分子量:209.60
  • EINESC号:

产品描述

物理化学性质

沸点 202.3±35.0 ºC (760 Tor
闪点 76.2±25.9 ºC, 计算值*
密度 1.353±0.06 g/cm3 (20 º

安全数据

没有数据没有数据

SDS

来源 SDS样本
没有数据没有数据
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Safety Evaluation of a Novel Strain ofYe Wang et al.Frontiers in microbiology, 8, 435-435 (2017-04-04) Origin of the 2-amino-2-deoxy-gluconate unit in Rhizobium leguminosarum lipid A. Expression cloning of the outer membrane oxidase LpxQ.Nanette L S Que-Gewirth et al.The Journal of biological chemistry, 278(14), 12120-12129 (2003-01-18) Structure of lipid A component of Rhizobium leguminosarum bv. phaseoli lipopolysaccharide. Unique nonphosphorylated lipid A containing 2-amino-2-deoxygluconate, galacturonate, and glucosamine.U R Bhat et al.The Journal of biological chemistry, 269(20), 14402-14410 (1994-05-20) Dihydropyrazine derivatives as a new type of DNA strand breaking agent.T Yamaguchi et al.Biological & pharmaceutical bulletin, 19(10), 1261-1265 (1996-10-01) In vivo effects of putative crowding factors on development of Hymenolepis diminuta.R L Cook et al.The Journal of parasitology, 77(1), 21-25 (1991-02-01) Developmental physiology of cestodes: characterization of putative crowding factors in Hymenolepis diminuta.E T Zavras et al.The Journal of parasitology, 70(6), 937-944 (1984-12-01) An outer membrane enzyme that generates the 2-amino-2-deoxy-gluconate moiety of Rhizobium leguminosarum lipid A.Nanette L S Que-Gewirth et al.The Journal of biological chemistry, 278(14), 12109-12119 (2003-01-18) Enzymatic synthesis of D-glucosaminic acid from D-glucosamine.Fabio Pezzotti et al.Carbohydrate research, 340(1), 139-141 (2004-12-29) N-methyl-1-glucosaminic acid.M L WOLFROM et al.Journal of the American Chemical Society, 68(11), 2343-2345 (1946-11-01) Confirmation of the structures of the products obtained on acylation of 2-amino-2-deoxy-D-gluconic acid.D Horton et al.Carbohydrate research, 193, 49-60 (1989-10-31) Chitosan modification and pharmaceutical/biomedical applications.Jiali Zhang et al.Marine drugs, 8(7), 1962-1987 (2010-08-18) Interaction of substituted hexose analogues with the Trypanosoma brucei hexose transporter.Laurent Azema et al.Biochemical pharmacology, 67(3), 459-467 (2004-03-24) A novel method to prepare water-dispersible magnetic nanoparticles and their biomedical applications: magnetic capture probe and specific cellular uptake.Changjiang Yu et al.Journal of biomedical materials research. Part A, 87(2), 364-372 (2008-01-09) N-Alkyl derivatives of 2-amino-2-deoxy-D-glucose.Beata Liberek et al.Carbohydrate research, 340(11), 1876-1884 (2005-06-28) Design of N-acetyl-6-sulfo-beta-d-glucosaminide-based inhibitors of influenza virus sialidase.Kenji Sasaki et al.Bioorganic & medicinal chemistry, 12(6), 1367-1375 (2004-03-17) Stereochemistry of an alpha, beta-elimination reaction by D-glucosaminate dehydratase.R Iwamoto et al.FEBS letters, 156(1), 33-36 (1983-05-30) Chromium(III) complexes of D-glucosaminic acid and their effect on decreasing blood sugar in vivo.Sheng-Ju Ou et al.Archiv der Pharmazie, 339(9), 527-530 (2006-08-31) Efficient production of D-glucosaminic acid from D-glucosamine by Pseudomonas putida GNA5.Bin Wu et al.Biotechnology progress, 27(1), 32-37 (2011-02-12) Use of D-glucosaminic acid as an internal standard in single-column accelerated amino acid analysis of physiological fluids.C Stacey-Schmidt et al.Analytical biochemistry, 123(1), 74-77 (1982-06-01) New chromogenic agar medium for the identification of Candida spp.Venitia M Cooke et al.Applied and environmental microbiology, 68(7), 3622-3627 (2002-06-29)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交